GNRO GeNeuro SA

Market: Euronext Paris ISIN code / Mnemo: CH0308403085 / GNRO Web site: www.geneuro.com

Regulatory News:

Pursuant to the liquidity contract entrusted by GENEURO SA (Paris:GNRO) to Gilbert Dupont, as of 28 June 2024, the following assets appeared on the liquidity account:

- Number of shares: 93,539 - Cash balance of the liquidity account: € 91,665.80

During the first half of 2024, the following shares were traded:

PURCHASES

174,683 shares

264,894.00 €

1,399 transactions

SALES

199,883 shares

307,583.09 €

1,210 transactions

As a reminder, as of 29 December 2023, the following resources were booked to the liquidity account:

- Number of shares: 118,739 - Cash balance of the liquidity account: € 48,977.59

It is also reminded that at the initial implementation of the contract, the following resources were included in the liquidity account:

▪ Number of shares: nil ▪ Cash: € 750,000.00

About GeNeuro

GeNeuro‘s mission is to develop safe and effective treatments against neurological disorders and autoimmune diseases, such as multiple sclerosis, by neutralizing causal factors encoded by HERVs, which represent 8% of human DNA.

For more information, visit: www.geneuro.com

APPENDIX

 

Achats

Ventes

 

Nombre de transactions

Nombre de titres

Capitaux en EUR

Nombre de transactions

Nombre de titres

Capitaux en

EUR

TOTAL

1 399

174 683

264 894,00

1 210

199 883

307 583,09

02/01/2024

5

383

444,29

23

3611

4281,74

03/01/2024

14

1701

1942,73

0

0

0

04/01/2024

4

529

587,39

11

1427

1621,84

05/01/2024

27

2227

3095,24

51

8633

12295,55

08/01/2024

37

4271

5873,36

9

1138

1603,56

09/01/2024

17

2500

3378,3

3

429

593,71

10/01/2024

14

1843

2395,43

2

600

750

11/01/2024

0

0

0

5

489

620,32

12/01/2024

9

981

1248,27

7

1597

2069,59

15/01/2024

7

1222

1557,99

2

202

260,58

16/01/2024

4

757

957,65

6

746

953,39

17/01/2024

4

460

586,18

1

210

269,85

18/01/2024

4

521

666,62

1

200

257

19/01/2024

9

1166

1475,84

0

0

0

22/01/2024

7

1051

1287,46

16

2974

3747,31

23/01/2024

13

1837

2261,03

6

796

984,45

24/01/2024

2

82

98,4

7

680

824,84

25/01/2024

8

425

517,16

13

1922

2356,75

26/01/2024

1

155

192,2

4

565

706,7

29/01/2024

4

538

676,81

2

101

128,78

30/01/2024

3

412

518,72

4

438

551,38

31/01/2024

2

80

100,8

4

364

458,64

01/02/2024

3

600

757,25

3

355

449,58

02/02/2024

44

5211

5964,39

23

4040

4689,29

05/02/2024

5

437

493,29

14

2378

2730,29

06/02/2024

5

985

1102,5

3

428

486,32

07/02/2024

3

750

840

0

0

0

08/02/2024

9

1376

1518,42

3

224

245,18

09/02/2024

7

928

991,99

6

800

866,34

12/02/2024

10

1633

1772,16

6

1879

2059,73

13/02/2024

10

1746

1913,83

12

2370

2619,76

14/02/2024

16

2641

2873,09

10

2437

2702,46

15/02/2024

8

1993

2192,3

7

2380

2660,75

16/02/2024

4

750

825

2

350

388,5

19/02/2024

9

691

761,73

5

1600

1780

20/02/2024

11

1396

1513,97

3

432

473,04

21/02/2024

3

210

230,96

16

2835

3184,8

22/02/2024

3

201

238,39

10

3020

3641,8

23/02/2024

7

750

967,09

16

3902

5117,82

26/02/2024

7

1852

2399,58

6

169

217,26

27/02/2024

18

2102

2688,5

11

2453

3197,19

28/02/2024

17

1898

2405,19

5

170

214,06

29/02/2024

13

1908

2348,58

28

3038

3789,64

01/03/2024

20

2283

2830,95

7

1614

2018,16

04/03/2024

20

4183

4839,92

6

605

702,03

05/03/2024

3

243

283,1

2

300

351,5

06/03/2024

15

1648

1879,63

2

352

407,25

07/03/2024

0

0

0

6

351

399,04

08/03/2024

18

3290

3663,29

12

3046

3415,19

11/03/2024

6

940

1068,15

3

439

502,46

12/03/2024

2

410

466,35

9

4060

4857

13/03/2024

13

1102

1308

10

2243

2728,61

14/03/2024

2

100

124

5

849

1067,37

15/03/2024

10

1223

1519,93

7

1383

1753,96

18/03/2024

16

1313

1647,77

0

0

0

19/03/2024

10

1256

1539,78

1

63

77,49

20/03/2024

5

1055

1290,13

20

6534

8143,01

21/03/2024

4

500

636,4

0

0

0

22/03/2024

0

0

0

4

1050

1327,38

25/03/2024

7

1304

1653,07

4

806

1032,27

26/03/2024

3

175

227,38

9

1480

1924,75

27/03/2024

5

849

1105,22

5

1164

1519,72

28/03/2024

1

180

234

15

2937

3923,16

02/04/2024

2

302

421,78

13

1864

2625,39

03/04/2024

9

684

968,55

8

1247

1782,8

04/04/2024

9

902

1280,23

2

350

497

05/04/2024

23

1837

2736,56

12

1818

2642,55

08/04/2024

7

1060

1561,32

4

250

371,27

09/04/2024

3

307

453,1

11

1341

1985,71

10/04/2024

11

1321

1966,84

14

1680

2514,64

11/04/2024

5

240

357,81

5

783

1172,74

12/04/2024

11

1946

2903,68

0

0

0

15/04/2024

7

1494

2194,13

3

600

886,5

16/04/2024

14

2041

2917,83

7

1850

2655,15

17/04/2024

12

1544

2204,77

7

1396

2012,96

18/04/2024

7

829

1195,75

1

65

93,93

19/04/2024

4

1372

1978,8

0

0

0

22/04/2024

0

0

0

3

650

932,76

23/04/2024

4

679

970,56

7

500

716

24/04/2024

2

250

357,5

0

0

0

25/04/2024

4

250

357

0

0

0

26/04/2024

0

0

0

0

0

0

29/04/2024

2

300

430,25

8

1556

2257,9

30/04/2024

11

1477

2126,17

10

1413

2050,89

02/05/2024

12

2074

2984,1

5

216

310,09

03/05/2024

0

0

0

10

1744

2562,02

06/05/2024

15

1771

2583,94

8

925

1387,71

07/05/2024

11

1959

2879,4

10

1970

2910,5

08/05/2024

12

1628

2424,31

18

4221

6351,46

09/05/2024

5

592

879,71

4

601

895,25

10/05/2024

13

1645

2430,76

7

1710

2549,11

13/05/2024

3

504

732,58

11

688

1015,2

14/05/2024

7

737

1102,34

14

911

1367,12

15/05/2024

8

552

869,97

10

1218

1888,48

16/05/2024

19

1511

2533,08

30

2615

4464,53

17/05/2024

20

1789

3257,08

42

3749

6839,01

20/05/2024

8

781

1546,38

15

1327

2573,76

21/05/2024

52

5082

9150,22

22

4168

7355,37

22/05/2024

23

3159

5573,78

22

3794

6696,94

23/05/2024

10

1834

3306,08

26

6507

12342,13

24/05/2024

13

1946

3845,41

2

129

253,36

27/05/2024

6

166

320,76

0

0

0

28/05/2024

5

337

649,56

7

699

1354,37

29/05/2024

24

3652

6956,19

9

2000

3932,29

30/05/2024

15

3600

6771,56

11

1559

2937,91

31/05/2024

8

2306

4369,82

18

4381

8396,21

03/06/2024

26

4317

8284,85

23

3206

6297,58

04/06/2024

4

75

149,53

16

4118

8305,91

05/06/2024

14

1362

2958,73

37

7406

16355,4

06/06/2024

20

2580

5746

17

2480

5738,68

07/06/2024

27

3494

7502,5

15

1233

2794,57

10/06/2024

22

2347

4664,87

4

869

1761,93

11/06/2024

27

1754

3694,92

28

6061

12919,29

12/06/2024

19

2036

3976,37

28

3344

6661,93

13/06/2024

16

2198

4406,69

3

159

317,82

14/06/2024

29

2928

5455,48

4

365

641,14

17/06/2024

5

563

973,99

15

2511

4444,01

18/06/2024

17

2313

3976,31

3

596

1019,16

19/06/2024

24

2968

4827,78

17

1934

3218,34

20/06/2024

30

2809

4527

9

1132

1829,42

21/06/2024

13

937

1495,94

10

1971

3263,33

24/06/2024

10

770

1280,23

29

3144

5536,79

25/06/2024

32

3592

6677,29

33

4447

8517,08

26/06/2024

47

4528

8284,53

5

421

779,05

27/06/2024

14

1399

2484,18

5

333

600,51

28/06/2024

0

0

0

0

0

0

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20240703859984/en/

GeNeuro’s contacts: GeNeuro Jesús Martin-Garcia Chairman and CEO +41 22 552 4800 investors@geneuro.com

NewCap (France) Louis-Victor Delouvrier (investors) +33 1 44 71 98 52 Arthur Rouillé (media) +33 1 44 71 94 98 geneuro@newcap.eu